Johnson & Johnson’s Rybrevant is on the brink of EU approval as a treatment for a subset of patients with newly diagnosed EGFR-positive lung cancer, after a recommendation from the EMA’s Human ...
AstraZeneca’s Tagrisso could face some serious competition as a first-line targeted therapy for advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC), in the shape of a new two-drug ...
The creator of the ABC sitcom talks to The Hollywood Reporter about what's to come for Janine and Gregory next week, and what ...
Monday - Friday, 6:00 - 7:00 PM ET United States: Monday - Friday 6 PM ET Australia: Saturday 09:00, 22:00, 23:00 SYD Sunday 22:00, 23:00 SYD Monday 04:00, 05:00 SYD "Mad Money Manifesto" by Jim ...
With the NFL Draft less than two weeks away, the Pittsburgh Steelers on Wednesday unveiled new details about the fan experiences planned for the event. The team’s official fan hub, called Steelers ...
The Rasmussen Reports daily Presidential Tracking Poll for Friday shows that 46% of Likely U.S. Voters approve of President Trump’s job performance. Fifty-two (52%) disapprove. The latest figures ...
Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results